# A Study to Evaluate the Safety and Efficacy of BOL-DP-o-08 in Patients With Endometriosis Syndrome.

> **NCT04174911** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Breath of Life International Pharma Ltd**

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** BOL-DP-o-08
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04174911
- **Lead sponsor:** Breath of Life International Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-01
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** covid 19
- **Last updated:** 2022-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04174911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04174911, "A Study to Evaluate the Safety and Efficacy of BOL-DP-o-08 in Patients With Endometriosis Syndrome.". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04174911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*